Apr 15 |
Shareholders in LivaNova (NASDAQ:LIVN) have lost 34%, as stock drops 3.1% this past week
|
Mar 21 |
LivaNova to Announce First-Quarter 2024 Results
|
Mar 21 |
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
|
Mar 20 |
LivaNova gains after positive predictive outcome of sleep apnea study
|
Mar 20 |
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
|
Mar 19 |
Returns On Capital Signal Difficult Times Ahead For LivaNova (NASDAQ:LIVN)
|
Mar 6 |
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
|
Mar 4 |
LivaNova to offer $300M convertible senior notes due
|
Mar 4 |
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
|
Mar 4 |
LivaNova to Present at the Barclays Global Healthcare Conference
|